The Prevalence of Latent Mycobacterium tuberculosis Infection Based on an Interferon-γ Release Assay: A Cross-Sectional Survey among Urban Adults in Mwanza, Tanzania

PLoS ONE

Volumn 8, Issue 5, 2013, Pages

  Jensen, Andreas V ^a   Jensen, Lotte ^a   Faurholt Jepsen, Daniel ^b   Aabye, Martine G ^b   Praygod, George ^c   Kidola, Jeremiah ^c   Faurholt Jepsen, Maria ^b   Changalucha, John ^c   Range, Nyagosya ^c   Krarup, Henrik ^d   Friis, Henrik ^b   Andersen, Aase B ^a  

^a ODENSE UNIVERSITY HOSPITAL   (Denmark)

^b UNIVERSITY OF COPENHAGEN   (Denmark)

^c NATIONAL INSTITUTE FOR MEDICAL RESEARCH   (Tanzania)

^d AALBORG UNIVERSITY HOSPITAL   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; OROSOMUCOID;

ADULT; AGE; ARTICLE; BLOOD SAMPLING; BODY MASS; CD4 LYMPHOCYTE COUNT; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; CYTOKINE RELEASE; FEMALE; GENDER; HIV TEST; HOUSEHOLD; HUMAN; INFLAMMATION; LATENT TUBERCULOSIS; LUNG TUBERCULOSIS; MAJOR CLINICAL STUDY; MALE; PREVALENCE; PROTEIN BLOOD LEVEL; QUESTIONNAIRE; TANZANIA; URBAN AREA; COINFECTION; HIV INFECTIONS; INTERFERON GAMMA RELEASE ASSAY; MIDDLE AGED; URBAN POPULATION; YOUNG ADULT;

ADULT; COINFECTION; CROSS-SECTIONAL STUDIES; FEMALE; HIV INFECTIONS; HUMANS; INTERFERON-GAMMA RELEASE TESTS; LATENT TUBERCULOSIS; MALE; MIDDLE AGED; PREVALENCE; TANZANIA; URBAN POPULATION; YOUNG ADULT;

EID: 84877939106     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0064008     Document Type: Article

References (24)

1. Rangaka MX, Wilkinson KA, Glynn JR, Ling D, Menzies D, et al. (2011) Predictive value of interferon-gamma release assays for incident active tuberculosis: a systematic review and meta-analysis. Lancet Infect Dis.
2. Menzies D, Al JH, Al OB, (2011) Recent developments in treatment of latent tuberculosis infection. Indian J Med Res 133: 257-266.
3. Dye C, Bourdin TB, Lonnroth K, Roglic G, Williams BG, (2011) Nutrition, diabetes and tuberculosis in the epidemiological transition. PLoS One 6: e21161.
4. Farhat M, Greenaway C, Pai M, Menzies D, (2006) False-positive tuberculin skin tests: what is the absolute effect of BCG and non-tuberculous mycobacteria? Int J Tuberc Lung Dis 10: 1192-1204.
5. Lalvani A, (2007) Diagnosing tuberculosis infection in the 21st century: new tools to tackle an old enemy. Chest 131: 1898-1906.
6. Pai M, Kalantri S, Dheda K, (2006) New tools and emerging technologies for the diagnosis of tuberculosis: part I. Latent tuberculosis. Expert Rev Mol Diagn 6: 413-422.
7. Hernandez-Pando R, Arriaga AK, Panduro CA, Orozco EH, Larriva-Sahd J, et al. (1998) The response of hepatic acute phase proteins during experimental pulmonary tuberculosis. Exp Mol Pathol 65: 25-36.
8. Almeida ML, Barbieri MA, Gurgel RQ, Abdurrahman ST, Baba UA, et al. (2009) alpha1-acid glycoprotein and alpha1-antitrypsin as early markers of treatment response in patients receiving the intensive phase of tuberculosis therapy. Trans R Soc Trop Med Hyg 103: 575-580.
9. Praygod G, Range N, Faurholt-Jepsen D, Jeremiah K, Faurholt-Jepsen M, et al. (2011) The effect of energy-protein supplementation on weight, body composition and handgrip strength among pulmonary tuberculosis HIV-co-infected patients: randomised controlled trial in Mwanza, Tanzania. Br J Nutr 1-9.
10. Praygod G, Range N, Faurholt-Jepsen D, Jeremiah K, Faurholt-Jepsen M, et al. (2011) Daily multi-micronutrient supplementation during tuberculosis treatment increases weight and grip strength among HIV-uninfected but not HIV-infected patients in Mwanza, Tanzania. J Nutr 141: 685-691.
11. World Health Organization (2009) AIDS Epidemic Update.
12. Corbett EL, Watt CJ, Walker N, Maher D, Williams BG, et al. (2003) The growing burden of tuberculosis: global trends and interactions with the HIV epidemic. Arch Intern Med 163: 1009-1021.
13. Sheriff FG, Manji KP, Manji MP, Chagani MM, Mpembeni RM, et al. (2010) Latent tuberculosis among pregnant mothers in a resource poor setting in Northern Tanzania: a cross-sectional study. BMC Infect Dis 10: 52.
14. Idh J, Abate E, Westman A, Elias D, Janols H, et al. (2010) Kinetics of the QuantiFERON-TB Gold In-Tube test during treatment of patients with sputum smear-positive tuberculosis in relation to initial TST result and severity of disease. Scand J Infect Dis 42: 650-657.
15. Nair SS, Ramanath RG, Chandrasekhar P, (1971) Distribution of Tuberculous infection and disease in clusters of rural households. The Indian Journal of Tuberculosis XVIII: 3-9.
16. Aabye MG, Ravn P, Praygod G, Jeremiah K, Mugomela A, et al. (2009) The impact of HIV infection and CD4 cell count on the performance of an interferon gamma release assay in patients with pulmonary tuberculosis. PLoS One 4: e4220.
17. Herrera V, Perry S, Parsonnet J, Banaei N, (2011) Clinical application and limitations of interferon-gamma release assays for the diagnosis of latent tuberculosis infection. Clin Infect Dis 52: 1031-1037.
18. World Health Organization stop TB Department (2010) Use of tuberculosis interferon-gamma release assays (IGRAs) in low- and middle- income countries policy statement. 1-60.
19. Pai M, Riley LW, Colford JM Jr, (2004) Interferon-gamma assays in the immunodiagnosis of tuberculosis: a systematic review. Lancet Infect Dis 4: 761-776.
20. Hochepied T, Berger FG, Baumann H, Libert C, (2003) Alpha(1)-acid glycoprotein: an acute phase protein with inflammatory and immunomodulating properties. Cytokine Growth Factor Rev 14: 25-34.
21. Johnson DA, Smith KD, (2006) The efficacy of certain anti-tuberculosis drugs is affected by binding to alpha-1-acid glycoprotein. Biomed Chromatogr 20: 551-560.
22. Herder C, Baumert J, Zierer A, Roden M, Meisinger C, et al. (2011) Immunological and cardiometabolic risk factors in the prediction of type 2 diabetes and coronary events: MONICA/KORA Augsburg case-cohort study. PLoS One 6: e19852.
23. Young F, Critchley JA, Johnstone LK, Unwin NC, (2009) A review of co-morbidity between infectious and chronic disease in Sub Saharan Africa: TB and diabetes mellitus, HIV and metabolic syndrome, and the impact of globalization. Global Health 5: 9.
24. Faurholt-Jepsen D, Range N, Praygod G, Jeremiah K, Faurholt-Jepsen M, et al. (2011) Diabetes is a risk factor for pulmonary tuberculosis: a case-control study from Mwanza, Tanzania. PLoS One 6: e24215.